IX 709 (Dexmethylphenidate Hydrochloride Extended-Release 25 mg)
Pill with imprint IX 709 is Beige, Capsule-shape and has been identified as Dexmethylphenidate Hydrochloride Extended-Release 25 mg. It is supplied by Amneal Pharmaceuticals LLC.
Dexmethylphenidate is used in the treatment of adhd and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Dexmethylphenidate 25 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).
Images for IX 709
Dexmethylphenidate Hydrochloride Extended-Release
- Imprint
- IX 709
- Strength
- 25 mg
- Color
- Beige
- Size
- 18.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Cns stimulants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- 2 - High potential for abuse
- Labeler / Supplier
- Amneal Pharmaceuticals LLC
- National Drug Code (NDC)
- 00115-1709
- Inactive Ingredients
-
acetyltributyl citrate,
ethylcelluloses,
hypromelloses,
hypromellose acetate succinate 06081224 (3 mm2/s),
sucrose,
corn starch,
magnesium silicate,
gelatin,
ferrosoferric oxide,
shellac,
potassium hydroxide,
propylene glycol
Note: Inactive ingredients may vary.
More about dexmethylphenidate
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 218 Reviews
- Drug class: CNS stimulants
- FDA Alerts (1)
Consumer resources
- Patient Information
- Dexmethylphenidate (Advanced Reading)
- Dexmethylphenidate Tablets
- Dexmethylphenidate Extended-Release Capsules
- Other brands
- Focalin, Focalin XR
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.